Paper List
-
Mapping of Lesion Images to Somatic Mutations
This paper addresses the critical bottleneck of delayed genetic analysis in cancer diagnosis by predicting a patient's full somatic mutation profile d...
-
Reinventing Clinical Dialogue: Agentic Paradigms for LLM‑Enabled Healthcare Communication
This paper addresses the core challenge of transforming reactive, stateless LLMs into autonomous, reliable clinical dialogue agents capable of longitu...
GOPHER: Optimization-based Phenotype Randomization for Genome-Wide Association Studies with Differential Privacy
Department of Biomedical Informatics & Data Science, Yale School of Medicine | Department of Technology and Operations Management, Harvard Business School | Department of Computer Science, Yale University
The 30-Second View
IN SHORT: This paper addresses the core challenge of balancing rigorous privacy protection with data utility when releasing full GWAS summary statistics, overcoming the limitations of prior methods that either add excessive noise or restrict output to a small subset of results.
Innovation (TL;DR)
- Methodology Introduces an optimization-based phenotype randomization mechanism (GOPHER-LP) that directly minimizes expected error in GWAS statistics, formulated as a linear programming problem to enhance utility beyond baseline methods like randomized response.
- Methodology Proposes GOPHER-MultiLP, which incorporates personalized priors derived from predictive models (e.g., polygenic risk scores) trained on a held-out subset, enabling sample-specific optimization that leverages genotype information to further reduce noise.
- Theory Adopts and extends the concept of phenotypic differential privacy (analogous to label DP), focusing protection on sensitive phenotypes while treating genotypes as public, providing a practical middle ground between full DP and unrestricted release.
Key conclusions
- The GOPHER framework enables the release of complete GWAS statistics (e.g., over 500,000 variants) with provable privacy guarantees, a significant scalability advance over prior methods limited to releasing only 3-5 top associations.
- Experiments on UK Biobank data (n=100,000) demonstrate that the mechanisms yield association statistics that accurately match non-private GWAS results while maintaining rigorous (ε, δ)-DP guarantees.
- The phenotype-randomization approach decouples the added noise from the number of genetic variants analyzed, addressing a fundamental scalability challenge not previously solved in the DP-GWAS literature.
Abstract: Genome-wide association studies (GWAS) are an essential tool in biomedical research for identifying genetic factors linked to health and disease. However, publicly releasing GWAS summary statistics poses well-recognized privacy risks, including the potential to infer an individual’s participation in the study or to reveal sensitive phenotypic information (e.g., disease status). While differential privacy (DP) offers a rigorous mathematical framework for mitigating these risks, existing DP techniques for GWAS either introduce excessive noise or restrict the release to a limited set of results. In this work, we present practical DP mechanisms for releasing the complete set of genome-wide association statistics with privacy guarantees. We demonstrate the accuracy of the privacy-preserving statistics released by our mechanisms on a range of GWAS datasets from the UK Biobank, utilizing both real and simulated phenotypes. We introduce two key techniques to overcome the limitations of prior approaches: (1) an optimization-based randomization mechanism that directly minimizes the expected error in GWAS results to enhance utility, and (2) the use of personalized priors, derived from predictive models privately trained on a subset of the dataset, to enable sample-specific optimization which further reduces the amount of noise introduced by DP. Overall, our work provides practical tools for accurately releasing comprehensive GWAS results with provable protection of study participants.